BackGamida Cell Overview

Gamida Cell Other Liabilities

Latest other liabilities for GMDA: $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Gamida Cell Other Liabilities History

Loading

Gamida Cell vs. peers: Other Liabilities Comparison

Loading

Gamida Cell Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Gamida Cell (GMDA) FAQ

As of the most recent data (March 2024), GMDA shows a other liabilities of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GMDA's other liabilities is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Gamida Cell is outperforming or lagging.

Tracking GMDA's other liabilities over time shows whether Gamida Cell is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Gamida Cell's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $0) with ownership activity and broader fundamentals.

Gamida Cell's other liabilities is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.